Anti-Human CD279 Recombinant Antibody(Cemiplimab)
-
产品编号
YR1516
-
别名
科研级 Cemiplimab ( 西米普利单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Cemiplimab ( 西米普利单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab |
| Catalog Number | YR1516 |
| Molecular Name | Cemiplimab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG4 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway. |
| CAS Number | 1801342-60-8 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD279[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
